Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine added to dexmedetomidine and remifentanil for liposuction anesthesia
ChiCTR2400080363Phase 4Recruiting
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in None (2 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoint: Patient and surgical team satisfaction scores. Started Dec 2023; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2400080363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080363.